Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 24 May 2012 | By Alexander Gaffney, RAC
Australia's Therapeutic Goods Administration (TGA) is calling for comments on a new proposed review to change the way labeling information is situated on medicinal product packaging.
The proposed changes would apply to both over-the-counter (OTC) and prescription products, and are aimed at making the medicines safer to use by making information easier to understand. Before formulating new regulations, TGA is calling for public and industry input on what changes should be made to product labels.
The review is set to look nine aspects of labeling:
Comments to TGA are due by 24 August, and may be submitted to firstname.lastname@example.org.
TGA - TGA Medicine Labelling and Packaging ReviewConsultation Paper
Summary: TGA medicine labelling and packaging review
Tags: Comments, Latest News, review